- Home
- FNWD vs SLDB Comparison
FNWD vs SLDB Comparison
Compare FNWD & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWD
- SLDB
- Stock Information
- Founded
- FNWD 1994
- SLDB 2013
- Country
- FNWD United States
- SLDB United States
- Employees
- FNWD N/A
- SLDB N/A
- Industry
- FNWD Savings Institutions
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FNWD Finance
- SLDB Health Care
- Exchange
- FNWD Nasdaq
- SLDB Nasdaq
- Market Cap
- FNWD 115.0M
- SLDB 124.7M
- IPO Year
- FNWD N/A
- SLDB 2018
- Fundamental
- Price
- FNWD $26.50
- SLDB $5.78
- Analyst Decision
- FNWD
- SLDB Strong Buy
- Analyst Count
- FNWD 0
- SLDB 12
- Target Price
- FNWD N/A
- SLDB $17.83
- AVG Volume (30 Days)
- FNWD 5.0K
- SLDB 5.3M
- Earning Date
- FNWD 01-28-2025
- SLDB 03-12-2025
- Dividend Yield
- FNWD 1.81%
- SLDB N/A
- EPS Growth
- FNWD 44.90
- SLDB N/A
- EPS
- FNWD 2.84
- SLDB N/A
- Revenue
- FNWD $71,597,000.00
- SLDB N/A
- Revenue This Year
- FNWD N/A
- SLDB N/A
- Revenue Next Year
- FNWD $7.73
- SLDB N/A
- P/E Ratio
- FNWD $9.35
- SLDB N/A
- Revenue Growth
- FNWD 12.66
- SLDB N/A
- 52 Week Low
- FNWD $22.82
- SLDB $2.88
- 52 Week High
- FNWD $33.50
- SLDB $15.05
- Technical
- Relative Strength Index (RSI)
- FNWD 40.20
- SLDB 69.94
- Support Level
- FNWD $26.16
- SLDB $3.15
- Resistance Level
- FNWD $27.05
- SLDB $7.20
- Average True Range (ATR)
- FNWD 0.50
- SLDB 0.63
- MACD
- FNWD 0.11
- SLDB 0.37
- Stochastic Oscillator
- FNWD 28.79
- SLDB 67.13
About FNWD Finward Bancorp
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.